Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TFPI | P10646 | 1/20 | 0.48 |
| ▸ | HRH1 | P35367 | 1/20 | 0.46 |
| ▸ | IL23R | Q5VWK5 | 4/20 | 0.44 |
| ▸ | F2 | P00734 | 1/20 | 0.43 |
| ▸ | NPY4R | P50391 | 3/20 | 0.42 |
| ▸ | NPY1R | P25929 | 2/20 | 0.42 |
| ▸ | NPY2R | P49146 | 2/20 | 0.42 |
| ▸ | NPY5R | Q15761 | 2/20 | 0.42 |
| ▸ | QRFPR | Q96P65 | 1/20 | 0.42 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22374514 | 0.90 | TFPI (0.56) | TFPIHRH1IL23ROPRL1 | |
| SCHEMBL22374947 | 0.88 | C5AR1 (0.46) | TFPIIL23R | |
| SCHEMBL22374967 | 0.86 | TFPI (0.51) | TFPIIL23RNPY4RNPY1RNPY2R | |
| SCHEMBL22374590 | 0.84 | TFPI (0.58) | TFPIHRH1IL23ROPRL1 | |
| SCHEMBL22375042 | 0.84 | TFPI (0.51) | TFPIHRH1IL23RF2NPY4R | |
| SCHEMBL22374703 | 0.83 | NPY4R (0.52) | NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL29993768 | 0.83 | NPY4R (0.55) | TFPINPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL29993329 | 0.83 | NPY4R (0.55) | TFPINPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL22374939 | 0.82 | TFPI (0.51) | TFPIHRH1IL23RF2NPY4R | |
| SCHEMBL22375094 | 0.82 | TFPI (0.55) | TFPIHRH1IL23RF2OPRL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200268897-A1 | Phosphatase Binding Compounds and Methods of Using Same | YALE UNIVERSITY | 2020-08-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200268897-A1 | Phosphatase Binding Compounds and Methods of Using Same | PPP5C, PPP4C, DUSP26 | TFPI 2882/4885HRH1 4831/4885IL23R 4642/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.